Approval · Notice of Compliance 13864 · 2012
CERENIA: Notice of Compliance 13864
Issued November 21, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13864
- Date
- November 21, 2012
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Chane to Dosage and Administration
- Therapeutic class
- Antiemetic
Products in this notice
Medicinal ingredients
- MAROPITANT CITRATE 16 MG per TAB
- MAROPITANT CITRATE 24 MG per TAB
- MAROPITANT CITRATE 60 MG per TAB
- MAROPITANT CITRATE 160 MG per TAB